AAAAAA
Results: 1-25/39
Authors:
LAMBERT MT
GARVER DL
Citation: Mt. Lambert et Dl. Garver, MENTORING PSYCHIATRIC TRAINEES FIRST PAPER FOR PUBLICATION, Academic psychiatry, 22(1), 1998, pp. 47-55
Authors:
VAWTER MP
HEMPERLY JJ
FREED WJ
GARVER DL
Citation: Mp. Vawter et al., CSF N-CAM IN NEUROLEPTIC-NAIVE FIRST-EPISODE PATIENTS WITH SCHIZOPHRENIA, Schizophrenia research, 34(3), 1998, pp. 123-131
Authors:
GARVER DL
NAIR TR
CHRISTENSEN JD
HOLCOMB J
KINGSBURY SJ
Citation: Dl. Garver et al., TYPOLOGY OF SCHIZOPHRENIA - STATIC VS ATROPHIC BRAIN PSYCHOSES - PREMORBIDITY, SYMPTOMS, AND NEUROLEPTIC EFFECTS, Schizophrenia research, 29(1-2), 1998, pp. 76-77
Authors:
KNOLL JL
GARVER DL
RAMBERG JE
KINGSBURY SJ
CROISSANT D
MCDERMOTT B
Citation: Jl. Knoll et al., HETEROGENEITY OF THE PSYCHOSES - IS THERE A NEURODEGENERATIVE PSYCHOSIS, Schizophrenia bulletin, 24(3), 1998, pp. 365-379
Authors:
KINGSBURY SJ
GARVER DL
Citation: Sj. Kingsbury et Dl. Garver, LITHIUM AND PSYCHOSIS REVISITED, Progress in neuro-psychopharmacology & biological psychiatry, 22(2), 1998, pp. 249-263
Authors:
MELTZER HY
CASEY DE
GARVER DL
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., MEASURING OUTCOME IN SCHIZOPHRENIA - DIFFERENCES AMONG THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 3-9
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., CLINICAL DEVELOPMENT OF ATYPICAL ANTIPSYCHOTICS - RESEARCH DESIGN ANDEVALUATION, The Journal of clinical psychiatry, 59, 1998, pp. 10-16
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ADVERSE-EFFECTS OF THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 17-22
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA S
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ASSESSMENT OF EPS AND TARDIVE-DYSKINESIA IN CLINICAL-TRIALS, The Journal of clinical psychiatry, 59, 1998, pp. 23-27
Authors:
MELTZER HY
CASEY DE
GARVER DL
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ASSESSING THE EFFECTS OF ATYPICAL ANTIPSYCHOTICS ON NEGATIVE SYMPTOMS, The Journal of clinical psychiatry, 59, 1998, pp. 28-34
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., EVALUATING THE EFFECTS OF ANTIPSYCHOTICS ON COGNITION IN SCHIZOPHRENIA, The Journal of clinical psychiatry, 59, 1998, pp. 35-40
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., ATYPICAL ANTIPSYCHOTICS FOR TREATMENT OF DEPRESSION IN SCHIZOPHRENIA AND AFFECTIVE-DISORDERS, The Journal of clinical psychiatry, 59, 1998, pp. 41-45
Authors:
MELTZER HY
CASEY DE
GARVER DL
LASAGNA L
MARDER SR
MASAND PS
MILLER D
PICKAR D
TANDON R
Citation: Hy. Meltzer et al., TREATMENT OF SPECIAL POPULATIONS WITH THE ATYPICAL ANTIPSYCHOTICS, The Journal of clinical psychiatry, 59, 1998, pp. 46-52
Authors:
GARVER DL
BARNES R
HOLCOMB J
FILBEY F
WILSON R
BOWCOCK A
Citation: Dl. Garver et al., GENOME-WIDE SCAN AND SCHIZOPHRENIA IN AFRICAN-AMERICANS, American journal of medical genetics, 81(6), 1998, pp. 454-455
Authors:
GARVER DL
Citation: Dl. Garver, THE ETIOLOGIC HETEROGENEITY OF SCHIZOPHRENIA, Harvard review of psychiatry, 4(6), 1997, pp. 317-327
Authors:
GARVER DL
NAIR TR
CHRISTENSEN JD
Citation: Dl. Garver et al., SCHIZOPHRENIA AS A CHRONIC ACTIVE BRAIN PROCESS - PERHAPS, BUT ONLY IN PART, PSYCHIATRY RESEARCH-NEUROIMAGING, 76(2-3), 1997, pp. 131-134
Authors:
NAIR TR
CHRISTENSEN JD
KINGSBURY SJ
KUMAR NG
TERRY WM
GARVER DL
Citation: Tr. Nair et al., PROGRESSION OF CEREBROVENTRICULAR ENLARGEMENT AND THE SUBTYPING OF SCHIZOPHRENIA, PSYCHIATRY RESEARCH-NEUROIMAGING, 74(3), 1997, pp. 141-150
Authors:
GARVER DL
CHRISTENSEN JD
NAIR TR
HOLCOMB J
KINGSBURY SJ
Citation: Dl. Garver et al., PREMORBID FUNCTIONING, SYMPTOMS AND RESPONSE IN EXPANDING VS NONEXPANDING VENTRICLE SCHIZOPHRENIC PSYCHOSES, Schizophrenia research, 24(1-2), 1997, pp. 145-146
Authors:
GARVER DL
STEINBERG JL
MCDERMOTT BE
YAO JK
RAMBERG JE
LEWIS S
KINGSBURY SJ
Citation: Dl. Garver et al., ETIOLOGIC HETEROGENEITY OF THE PSYCHOSES - IS THERE A DOPAMINE PSYCHOSIS, Neuropsychopharmacology, 16(3), 1997, pp. 191-201
Authors:
OTTONG SE
GARVER DL
Citation: Se. Ottong et Dl. Garver, A BIOMODAL DISTRIBUTION OF PLASMA HVA MHPG IN THE PSYCHOSES/, Psychiatry research, 69(2-3), 1997, pp. 97-103
Authors:
FILBEY FM
HOLCOMB J
FULTON M
NAIR TR
CHRISTENSEN JD
GARVER DL
Citation: Fm. Filbey et al., NEGATIVE SYMPTOMS OF EXPANDING-VENTRICLE SCHIZOPHRENIAS BREED TRUE, American journal of medical genetics, 74(6), 1997, pp. 596-596
Authors:
CHRISTENSEN JD
GARVER DL
Citation: Jd. Christensen et Dl. Garver, BRAIN PHOSPHORYLATION POTENTIAL CHANGES FOLLOWING SMOKING IN CONTROLSAND SCHIZOPHRENICS, Biological psychiatry, 41, 1997, pp. 405-405
Authors:
GRIFFITH JM
ONEILL JE
PETTY F
GARVER DL
Citation: Jm. Griffith et al., EFFECT OF NICOTINE AND STAGE-2 SLEEP ON AUDITORY P50 GATING IN SCHIZOPHRENIA, Biological psychiatry, 39(7), 1996, pp. 518-518
Authors:
STONE CK
GARVER DL
Citation: Ck. Stone et Dl. Garver, HALOPERIDOL DOSING STRATEGIES - REPLY, The American journal of psychiatry, 153(8), 1996, pp. 1109-1109
Authors:
GARVER DL
GRIFFITH J
STEINBERG J
KUMAR NG
Citation: Dl. Garver et al., THE GROUP OF THE SCHIZOPHRENIAS .2. DEGENERATIVE PSYCHOSIS, Schizophrenia research, 15(1-2), 1995, pp. 83-83